The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis. X-15439
-
Page/Page column 96
(2010/02/11)
BRIDGED RING STRUCTURES AS PHARMACEUTICAL AGENTS
The present invention is directed to 1α,25-dihydroxyvitamin D3 mimics which modulate the vitamin D receptor (VDR). The invention is further directed to pharmaceutical compositions and methods for the treatment, prevention or amelioration of one or more sy
-
Page/Page column 84
(2010/02/11)
More Articles about upstream products of 850918-21-7